Chimeric antigen receptor T-cell (CAR T) therapy is a kind of effective cancer immunotherapy.However,designing CARs remains a challenge because many targetable
The majority of cancer drugs entering clinical trials fail to reach the market due to poor efficacy. Preclinicalefficacy has been traditionally tested using sub